Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Apollo Therapeutics Ltd
City of Hope Medical Center
Fred Hutchinson Cancer Center
AB Science
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
SCRI Development Innovations, LLC
Celyad Oncology SA